Skip to content

A cohort study on the influence of TCM wet syndrome status on the prognosis of patients with obesity complicated with diabetes

A cohort study on the influence of TCM wet syndrome status on the prognosis of patients with obesity complicated with diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068581
Enrollment
Unknown
Registered
2023-02-23
Start date
2023-02-23
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity with Diabetes Mellitus

Interventions

Dampness syndrome group:N/A
Non-dampness syndrome group:N/A

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Patient age 18-65 years B. Meet the diagnostic criteria for obesity and diabetes, i.e., BMI=28 and symptoms of diabetes (such as dry mouth, polydipsia, polyuria, polyphagia, hunger, weight loss, itchy skin or blurred vision and other typical symptoms) plus: a random venous plasma glucose concentration = 11.1 mmol/l; or fasting blood glucose (FPG) concentration = 7.0mmol/l (whole blood =6.1mmol/l); or a two-hour blood glucose (2hPG) concentration or an oral glucose tolerance test (OGTT) of 75 g = 11.1 mmol/l, or obese patients with a previous diagnosis of diabetes C. Informed consent of the patient

Exclusion criteria

Exclusion criteria: A. Those who have developed diabetic complications: including diabetic eye disease, diabetic foot, diabetic nephropathy, Diabetic peripheral neuropathy; B. Infectious diseases, including diseases with a clear focus of infection or systemic infectious diseases; C. Pregnant and perinatal women; D. Serious primary diseases such as malignant tumors and liver cirrhosis, and secondary cardio-cerebral hemorrhages such as coronary heart disease and stroke Tube events, and people with mental illness. E. Patients who have developed diabetic complications: including diabetic eye disease, diabetic foot, diabetic nephropathy, Diabetic peripheral neuropathy (diabetic retinopathy on fundus examination, abnormal microalbumin in the urine, etc.).

Design outcomes

Primary

MeasureTime frame
Complication events;

Secondary

MeasureTime frame
Body measurement;Blood pressure;heart rate;InBody composition;TCM Physique Questionnaire;Traditional Chinese medicine tongue image;TCM wet evidence scale;Fasting blood sugar;Triglycerides;Blood sugar two hours after meals;Glycated albumin;Glycated hemoglobin;Fasting insulin;Fasting C peptide;Blood urea;Urine red blood cells;Urogenic stereotyping test;Urine microalbumin;

Countries

China

Contacts

Public ContactLiangCuimei

Dongfang Hospital Beijing University of Chinese Medicine

christine_lcm@163.com18511284813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026